Oxford University VR spinout demonstrates significant psychotherapy benefits in Lancet study

Oxford University VR spinout demonstrates significant psychotherapy benefits in Lancet study

Virtual reality can help treat symptoms in patients with psychosis, according to a new study published in The Lancet Psychiatry.

GameChangeVR automates psychotherapy, guiding users with a virtual coach. It was developed by OxfordVR, a digital therapeutics company, the University of Oxford and Oxford Health NHS Foundation Trust. In an announcement, OxfordVR claimed to be the first digital therapeutic to successfully show positive results in these types of patients and claimed this to be the largest ever clinical trial of VR for mental health. 

The study, based on 346 patients, found that automated VR therapy led to “significant reductions” in symptoms of anxious avoidance and distress. The technology especially benefited those with severe symptoms. The study concluded that the technology has the potential to increase access to effective care for psychosis.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 20, 2024 at 1:14pm